Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

(2019) Oliver Preische et al.   NATURE MEDICINE

Serum homocysteine level is related to cerebral small vessel disease in a healthy population

(2019) Ki-Woong Nam et al.   NEUROLOGY

IL-1α and IL-6 predict vascular events or death in patients with cerebral small vessel disease—Data from the SHEF-CSVD study

(2019) Jacek Staszewski et al.   Advances in Medical Sciences

Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors

(2018) Daniela Pinter et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity

(2018) Esther M.C. van Leijsen et al.   STROKE

IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study

(2018) Jacek Staszewski et al.   Clinical Interventions in Aging

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden

(2018) Marco Duering et al.   Journal of Stroke

Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy

(2018) Esther M. C. van Leijsen et al.   HIPPOCAMPUS

Serum neurofilament light is sensitive to active cerebral small vessel disease

(2017) Thomas Gattringer et al.   NEUROLOGY

Nonlinear temporal dynamics of cerebral small vessel disease

(2017) Esther M.C. van Leijsen et al.   NEUROLOGY

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Automated detection of white matter hyperintensities of all sizes in cerebral small vessel disease

(2016) Mohsen Ghafoorian et al.   MEDICAL PHYSICS

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

Predictors and Clinical Impact of Incident Lacunes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy

(2016) Yifeng Ling et al.   STROKE

Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study

(2013) Lorena Blanco-Rojas et al.   BMC Neurology

Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease

(2013) M. Duering et al.   BRAIN

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

(2013) Joanna M Wardlaw et al.   LANCET NEUROLOGY

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol

(2011) Anouk GW van Norden et al.   BMC Neurology

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

(2010) Leonardo Pantoni   LANCET NEUROLOGY